Copyright
©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Sep 16, 2021; 9(26): 7840-7844
Published online Sep 16, 2021. doi: 10.12998/wjcc.v9.i26.7840
Published online Sep 16, 2021. doi: 10.12998/wjcc.v9.i26.7840
Extravasation of chemotherapeutic drug from an implantable intravenous infusion port in a child: A case report
Dan-Ni Lv, Li-Li Zheng, Li-Li Chen, A-Qin Ye, Department of Surgical Oncology, The Children’s Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou 310052, Zhejiang Province, China
Hong-Zhen Xu, Yun Ling, Department of Nursing, The Children’s Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou 310052, Zhejiang Province, China
Author contributions: Lv DN and Xu HZ carried out the study, participated in data collection, and drafted the manuscript; Zheng LL and Chen LL performed statistical analysis and participated in study design; Ling Y and Ye AQ participated in the acquisition, analysis, and interpretation of the data, and drafted the manuscript; all authors read and approved the final manuscript.
Supported by Department of Education of Zhejiang Province , China, No. Y201941241.
Informed consent statement: Informed written consent was obtained from the patient’s parents for publication of this report and any accompanying images.
Conflict-of-interest statement: The authors declare that they have no conflict of interest for this manuscript.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Hong-Zhen Xu, MD, Doctor, Department of Nursing, The Children’s Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, No. 3333 Binsheng Road, Binjiang District, Hangzhou 310052, Zhejiang Province, China. 6184020@zju.edu.cn
Received: March 18, 2021
Peer-review started: March 18, 2021
First decision: June 24, 2021
Revised: July 9, 2021
Accepted: July 23, 2021
Article in press: July 23, 2021
Published online: September 16, 2021
Peer-review started: March 18, 2021
First decision: June 24, 2021
Revised: July 9, 2021
Accepted: July 23, 2021
Article in press: July 23, 2021
Published online: September 16, 2021
Core Tip
Core Tip: This was a case of extravasation of a chemotherapeutic drug (paclitaxel) from an implantable infusion port in a 23-mo old child. After fully evaluating the skin at the site of extravasation, the nurse continued to use the infusion port to complete the follow-up chemotherapeutic course. The skin around the infusion port was red, and showed no ulceration, swelling, or induration at discharge.